{"id": "patient_01_q0", "generated_text": "D: Vincristine\n\nThe text for option D indicates that Vincristine is not part of the current treatment regimen. The current regimen includes Polatuzumab vedotin, Rituximab, Cyclophosphamide", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q0", "generated_text": "D: Vincristine\n\nExplanation: Vincristine is not listed in the current treatment regimen for Mrs. Sample's DLBCL. The regimen includes Polatuzumab vedotin, Rituximab, Cycloph", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q0", "generated_text": "D: Vincristine\nThe context provided does not mention Vincristine as part of the current treatment regimen for Mrs. Sample's DLBCL. The current treatment regimen includes Polatuzumab vedotin, Rituxim", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q1", "generated_text": "D: She has 3-vessel CHD.\n\nThe provided information states that Mrs. Sample has \"2-vessel CHD\" (coronary heart disease), not 3-vessel CHD. Therefore, option D is the statement that", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q1", "generated_text": "D: She has 3-vessel CHD.\n\nThe document states \"2-vessel CHD\" and does not mention 3-vessel CHD. Therefore, option D is the correct answer for the statement that is NOT accurate based on the", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q1", "generated_text": "D: She has 3-vessel CHD.\nThe provided context mentions \"2-vessel CHD\" and does not mention 3-vessel CHD. Therefore, the correct answer is D.\nA: She has 2-vessel disease", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q2", "generated_text": "A: Primary progressive type of multiple sclerosis (ID 03/02)\n\nThe context provided indicates that Mrs. Sample suffers from \"Primary progressive type of multiple sclerosis (ID 03/02)\".\n\nContext:\n**Other diagnoses**", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q2", "generated_text": "A: Primary progressive type of multiple sclerosis (ID 03/02)\nThe correct answer is A: Primary progressive type of multiple sclerosis (ID 03/02). This is mentioned in the \"Other diagnoses\" section of the", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q2", "generated_text": "A: Primary progressive type of multiple sclerosis (ID 03/02)\n\nThe provided context clearly mentions that Mrs. Sample has a diagnosis of \"Primary progressive type of multiple sclerosis (ID 03/02)\". This directly indicates that", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q3", "generated_text": "B: Fingolimod 0.5mg, 1 capsule at bedtime, Note: Take a break as directed\nAnswer: B: Fingolimod 0.5mg, 1 capsule at bedtime, Note:", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q3", "generated_text": "B: Fingolimod 0.5mg, 1 capsule at bedtime, Note: Take a break as directed\nAnswer: B: Fingolimod 0.5mg, 1 capsule at bedtime, Note:", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q3", "generated_text": "B: Fingolimod 0.5mg, 1 capsule at bedtime, Note: Take a break as directed\nAnswer: B: Fingolimod 0.5mg, 1 capsule at bedtime, Note:", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q4", "generated_text": "D: 6 cycles of R-Pola-CHP\n\nThe oncology board decision stated: **Oncology board decision: 6 cycles of R-Pola-CHP.** The therapy regime recommended by the oncology board for Mrs", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q4", "generated_text": "D: 6 cycles of R-Pola-CHP\nAnswer:  D: 6 cycles of R-Pola-CHP\n\n---\n\nQuery: What is the primary reason for discontinuing Fingolimod in Mrs. Sample's", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q4", "generated_text": "D: 6 cycles of R-Pola-CHP\nThe oncology board decision: 6 cycles of R-Pola-CHP. **D:** 6 cycles of R-Pola-CHP. Based on the provided context,", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q5", "generated_text": "C: Thoracic vertebra 10\n: There is a large intraspinal mass extending from T10-L1, causing an anterior spongy appearance of the spinal cord and resulting in complete spinal canal stenosis at this level", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q5", "generated_text": "C: Thoracic vertebra 10\nBased on the context provided, the metastasis that was surgically addressed is located at the thoracic vertebra 10 (T10). This can be inferred from the information given in the", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q5", "generated_text": "C: Thoracic vertebra 10\n\n**Explanation:** The context provided states, \"Tumor cuff T10. dignity? Entity? Macroscopy: 1st lamina T10: fixed. some assembled 0.7", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q6", "generated_text": "A: After uneventful intravenous administration of Omnipaque 320, a multi-slice helical CT of the chest, abdomen, and pelvis was performed during the venous phase of contrast enhancement. Additional oral contrast was given", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q6", "generated_text": "A: After uneventful intravenous administration of Omnipaque 320, a multi-slice helical CT of the chest, abdomen, and pelvis was performed during the venous phase of contrast enhancement.\n\n---\n\nContext for the next", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q6", "generated_text": "A: CT Chest/Abdomen/Pelvis + Contrast from 01/09/2017 Results: After uneventful intravenous administration of Omnipaque 320, a multi-slice helical CT", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q7", "generated_text": "B: MR Head 3D unenhanced + contrast from 12/19/2016 10:30 AM. MR Spine plain + post-contrast from 12/20/20", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q7", "generated_text": "B: The radiologic examinations are listed in the following order according to the document: MR Head (12/19/2016), MR Spine (12/20/2016), CT Thoracic Sp", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q7", "generated_text": "B: The patient received the following radiologic examinations in the order: MR Head from 12/19/2016, MR Spine from 12/20/2016, CT Thoracic Spine", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q8", "generated_text": "E: The patient started taking 2mg of Melatonin in the morning, as noted in the discharge medications.\n\n---\n\nContext: The discharge medications list states that the patient is to take 2mg of Melatonin at bedtime, not in the morning", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q8", "generated_text": "B: The patient started taking Pregabalin 75 mg, 1-0-1-0\nAnswer:  B: The patient started taking Pregabalin 75 mg, 1-0-1-0", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q8", "generated_text": "B: The patient started taking Pregabalin 75 mg, 1-0-1-0\nAnswer:  B: The patient started taking Pregabalin 75 mg, 1-0-1-0", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
{"id": "patient_01_q9", "generated_text": "B: The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake. B: The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake. At admission", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}}
{"id": "patient_01_q9", "generated_text": "B: The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake. B: The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake. The admission", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 1}}
{"id": "patient_01_q9", "generated_text": "B: The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake. The patient was taking 2 capsules of Hydromorphone hydrochloride (extended-release) 2mg in the morning", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 2}}
